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Rheumatic Heart Disease in Asia
Jonathan R. Carapetis, MBBS, PhD, FRACP, FAFPHM
A few years ago, my colleagues and I conducted a system-atic review of data relating to the global burden of group A
streptococcal diseases.1,2 Population-based data on rheumatic
heart disease prevalence from 1985 through 2002 were included.
We estimated that there were a minimum of 15.6 million people
in the world with rheumatic heart disease, with 282 000 new
cases each year and 233 000 resultant deaths each year; how-
ever, we also noted that the estimates of the number of cases in
school-aged children in China (176 500) and Asia Other
(102 000; Asia excluding South-Central Asia and China) were
based on very few studies, none of which used echocardiography
to confirm the presence of rheumatic heart disease lesions.
Moreover, 5 of the 6 studies included in the Asia Other estimate
came from 1 country, the Philippines. We therefore urged
caution in interpreting these data from Asia, other than South-
Central Asia, and concluded that there was an urgent need for
more population-based data from this part of the world. In the 5
years since that review was compiled, more data have emerged
to clarify the burden of rheumatic heart disease in Asia, which
will be summarized here.
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Methods
The previous report included Medline searches and other searches to
retrieve articles from 1980 to 2002 with population-based studies of
rheumatic heart disease prevalence. To update these data for the
present study, a Medline search was conducted with the terms
rheumatic fever or rheumatic heart disease and Asia. The abstracts
of all articles retrieved from 2003 through November 2007 were
reviewed, and the manuscripts of relevant articles were reviewed in
full. Population-based studies of the prevalence of rheumatic heart
disease in school-aged children were used to update the regional
prevalence estimates from the previous review. Additional studies in
other age groups and non–population-based studies were also re-
viewed if they were thought to possibly offer insights into the burden
of rheumatic heart disease in Asia.
Updated denominator data were obtained from the United Nations
Population Division (available at http://esa.un.org/unpp/, accessed
on February 15, 2008). Regions of Asia were divided in the same
way as the previous review: South-Central Asia (Afghanistan,
Bangladesh, Bhutan, India, Iran, Kazakhstan, Kyrgyzstan, Maldives,
Nepal, Pakistan, Sri Lanka, Tajikistan, Turkmenistan, and
Uzbekistan), China, and “Asia Other” (all other Asian countries).
The author takes full responsibility for the integrity of the data and
agrees to the manuscript as written.
Results
Five population-based prevalence studies of rheumatic heart
disease in school-aged children were found from South-
Central Asia since 2003,3–7 along with 1 from China8 and 1
from Asia Other.9 Interestingly, 4 of 5 recent studies from
South-Central Asia produced prevalence estimates substan-
tially lower (range 0.68 to 1.3 per 1000) than the pooled
estimate from this region in the previous review (2.2 per
1000), although 1 study from Pakistan gave a much higher
estimate (between 7 and 12 per 1000).4 By contrast, the newer
studies from China and Asia Other found prevalence rates
higher than the previous estimate from those regions. The
Chinese study reported a prevalence of 11 per 1000, which is
dramatically higher than other estimates from Asia, but it is
not clear whether echocardiographic confirmation was used
in the study (Table 1).8
The additional study from Asia Other is noteworthy. A
school-based survey conducted in Phnom-Penh found a
prevalence rate of echocardiographically confirmed clinical
rheumatic heart disease (ie, in children with significant
cardiac murmurs) of 2.2 per 1000.9 However, an additional
feature of that study was that all children had echocardiog-
raphy performed, with the result that many children without
clinically significant heart murmurs were also diagnosed with
rheumatic heart disease (the prevalence estimate increased
almost 10-fold, to 21.5 per 1000, with the inclusion of these
subclinical cases).
A household survey in rural Pakistan used rigorous meth-
odology and found an all-age prevalence of echocardiograph-
ically confirmed rheumatic heart disease of 5.7 per 1000.4
Unfortunately, detailed data on age subgroups were not
presented, but a graph of rheumatic heart disease prevalence
indicated a prevalence of 7 per 1000 in boys aged 5 to 14
years and 12 per 1000 in girls of the same age. The study also
found that the highest prevalence of rheumatic heart disease
in females occurred in those 45 to 54 years of age and in
males in those 55 to 64 years of age.
The data from these population-based prevalence studies in
school-aged children were used to estimate the total number
of rheumatic heart disease cases in Asia (Table 2). The
estimate from South-Central Asia (450 000 cases) should
be considered the most reliable, because it relied on 16
studies that used echocardiography. The estimate from China
is based on 2 studies, neither of which could be confirmed as
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having used echocardiography. The estimate from Asia high-
lights the variability of the overall estimate depending on
whether all studies are included (150 000 cases) or the 1
echocardiography-based study is used (390 000 cases). The
overall estimate is between 1.96 and 2.21 million cases of
rheumatic heart disease in Asian children 5 to 14 years of age.
In the previous review, we detailed 4 studies that allowed
an estimate of the proportion of rheumatic heart disease cases
in the total population that could be expected to be found in
the 5- to 14-year-old age group.16,26–28 We concluded that
number of cases in school-aged children should be multiplied
by 5.5 to 7.2 to estimate the total cases in all ages. The recent
Table 1. Studies Since 1985 of Rheumatic Heart Disease Prevalence in School-Aged Children in Asia
Reference Year of Study Place Age, y
RHD Prevalence
(per 1000) No. Screened No. of Cases Echo Type of Study
South-Central Asia
Grover et al10 1988–1991 India: north 5–15 2.1 31 200 66 Yes Community project
Kumar et al11 1988–1990 India: Rajasthan 3.5–18 3.3 10 168 34 Yes School survey
Vashistha et al12 1989–1990 India: Agra 5–15 1.4 8449 12 Yes School survey
Patel et al13 1986 India: Anand 5–15 1.8 11 069 20 ? Yes School survey
WHO14 1986 Pakistan: Islamabad 5–15 0.26 11 700 3 ? No School survey
Avasthi et al15 1987 India: Ludhiana 6–16 1.3 6005 8 ? Yes School survey
Agarwal et al16 1991–1992 India: Uttar Pradesh 0–15 6.4 3760 24 Yes Village screening
Thakur et al17,18 1990s India: north 5–16 2.9 15 080 44 Yes School survey
Gupta et al19 1991 India: Jammu City 6–16 1.4 10 263 14 Yes School survey
Shrestha et al20 1991 Nepal (rural) 5–16 1.4 4452 6 Yes School survey
Ahmed et al3 1991 Bangladesh (rural) 5–15 1.3 5923 8 Yes Community survey
Haque et al21 1992 Bangladesh: Dhaka
and Dhamrai
5–15 2.2 15 798 36 Yes School survey
Joardar et al22 1992 Bangladesh: Rajbari 5–20 1.45 686 1 No Community survey
Begum et al23 1993 Bangladesh: Dhaka 5–15 2.4 10 538 25 Yes School survey
Rizvi et al4 1993–1994 Pakistan: Rahim
Yaar Khan
5–14 7 to 12* NK* NK* Yes Household survey
Regmi and Pandey24 1997 Nepal: Kathmandu 5–16 1.2 4736 6 Yes School survey
Bahadur et al5 2002 Nepal: Kathmandu
Valley
5–18 1.2 9420 11 Yes School survey
Jose and Gomathi6 2001–2002 India: Vellore 6–18 0.68 229 829 157 Yes School survey
Periwal et al7 2005 India: Bikaner 5–14 0.67 3002 2 Yes School survey
China
WHO14 1986 Guangdong
Province
5–15 0.8 31 180 25 ? No School screening
Chen et al8 1993–1994 Sichuan Province 5–18 11 46 595 512 Unknown† Community survey
Asia Other
WHO14 1986 Thailand: Bangkok
and Nakornrajasima
5–15 0.2 55 465 9 No School survey
Guzman25 1987–1990 Philippines: Laguna 5–15 0.8 91 694 72 ? No School survey
Guzman25 1995–1997 Philippines: La
Union
5–15 1.0 28 554 29 ? No School survey
Guzman25 1996–1997 Philippines:
Mindanao
5–15 1.3 10 635 14 ? No School survey
Guzman25 1996–1997 Philippines: Albay 5–15 1.2 40 000 48 ? No School survey
WHO14 1986 Philippines: Laguna 5–15 1.6 17 320 27 ? No School survey
Marijon et al9 2001–2002 Cambodia:
Phnom-Penh
6–17 2.2‡ 3677 8 Yes School survey
RHD indicates rheumatic heart disease; WHO, World Health Organization; ?, not clear from publication if echocardiography was used (response likely inferred from
manuscript); and NK, not known.
*Household survey of all ages. Data not presented separately for school-aged children, except for graphical depiction of rheumatic heart disease prevalence, by
gender.
†Article in Chinese; only the English abstract was reviewed.
‡Prevalence estimate for those diagnosed clinically with echocardiographic confirmation. Separate estimate presented for screening of all children with
echocardiography: 79 cases, prevalence 21.5 per 1000 (ie, 90% of rheumatic heart disease cases were subclinical).
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study from Pakistan supports this: Although sufficient data
were not presented to make the same calculation, the graph-
ical illustration of rheumatic heart disease prevalence by age
group confirms that there was no decrease in prevalence (in
fact, rates peaked in older age groups) between the 5- to
14-year-olds and the 55- to 64-year-olds.4 Applying these
multiplication factors to the estimates in Table 2, one can
estimate that the total number of rheumatic heart disease
cases is between 10.8 million (lower estimate based on 5.5
multiplication factor and all studies) and 15.9 million (upper
estimate based on 7.2 multiplication factor and echocardio-
graphic studies only).
In the previous review, we pointed out that accurate
estimates of mortality due to rheumatic heart disease are not
possible because of the lack of data from developing coun-
tries. Our best estimates were based on an expected mortality
of 1.5% per year in rheumatic heart disease patients, which
was based on prospective studies from North America and the
United Kingdom during the 1960s.29–32 However, a 12-year
cohort study from India published in 2002 found a mortality
rate among rheumatic heart disease patients of 3.3% per
year.33 Applying this to the estimates in Table 2, we estimate
that rheumatic heart disease is directly responsible for
356 000 to 524 000 deaths each year in Asia.
Other Data
A number of recent publications added information regarding
rheumatic heart disease in Asia. A cross-sectional study of
8080 middle-aged to elderly people in China during 2001 to
2002 found a prevalence of 2 cases of echocardiographically
proven rheumatic heart disease per 1000 people.34 A 50-year
retrospective study from 2 hospitals in Shanghai, China,
found that cardiovascular admissions increased 3-fold over
this period but that the proportion due to rheumatic heart
disease declined 5-fold (from 50% to 10% of cardiac admis-
sions).35 A prospective study conducted in Lebanon from
1999 to 2005 found that rheumatic heart disease was the most
common acquired heart disease in children (36% of cases).36
Endocarditis
In the last review, all of the data published globally since
1980 documenting the association of infective endocarditis
and rheumatic heart disease had come from Asia. This
interest in endocarditis persisted: An additional 8 studies37–48
from Asia were found during the preparation of the present
Table 2. Estimated Number of Rheumatic Heart Disease Cases in Children 5 to 14 Years of Age in Asia
Region
No. of Studies
(No. Using Echo)
Median
RHD
Prevalence
No.
Screened
(All Studies)
RHD
Prevalence
(All Studies)
No. Screened
(Echo Studies)
RHD
Prevalence
(Echo Studies)
Population
Aged 5–14 y
Estimated RHD
Cases
(Using All Studies)
Estimated RHD
Cases
(Using Echo Studies)
South-Central
Asia
18 (16) 1.4 392 078 1.2 379 692 1.2 365 731 000 444 946 455 608
China 2 (0) 5.9 77 775 6.9 NA NA 198 485 000 1 370 446 NA
Asia Other 7 (1) 1.2 247 345 0.8 3677 2.2 178 694 000 149 547 388 782
Total 742 910 000 1 964 939 2 214 836*
Echo indicates echocardiography; RHD, rheumatic heart disease; and NA, not applicable because there were no echocardiographic studies.
Prevalences are per 1000.
*Includes all-studies estimate for China, because no echocardiographic studies were available.
Table 3. Studies Since 1980 Documenting the Association of Rheumatic Heart Disease and Infective Endocarditis in Asia
Reference Year of Study Country
Proportion of IE With RHD
as Predisposing Factor
Rank of RHD as Predisposing
Factor Notes/Mortality
Cetinkaya et al37 1974–1999 Turkey 65% Most common
Borer et al38 1980–1994 Israel 37% Most common Incidence IE 1.2 per 100 000 in 1990s;
deduced incidence of RHD-related
IE0.44 per 100 000
Choudhury et al39 1981–1991 India 42% Most common Mortality 25%
Dhawan et al40 1984–1990 India 49% Most common
Kanafani et al41 1986–2001 Lebanon 33% Most common
Lertsapcharoen et al42 1987–2004 Thailand 12% 2nd most common Congenital heart disease in 74%
Agarwal et al43 1987–1988 India 68% Most common Mortality 21%
Garg et al44 1992–2001 India 47% Most common
Heper and Yorukoglu45 1995–2000 Turkey 66% Most common
Yiu et al46 1995–2005 Hong
Kong
18% 2nd most common Incidence IE 2.8 per 100 000
Khanal et al47 1995–1997 India 56% Most common Mortality 30%
Liew et al48 1997–2004 Singapore 4% Rare Congenital heart disease in 89%
IE indicates infective endocarditis.
2750 Circulation December 16/23, 2008
 by guest on November 12, 2013http://circ.ahajournals.org/Downloaded from 
report (Table 3). The recent studies from India, Turkey, and
Lebanon all found that rheumatic heart disease was the most
common underlying factor in endocarditis (range 33% to
66%),41,44,45,47 whereas studies from Hong Kong and Thai-
land found rheumatic heart disease in 18% and 12% of cases,
respectively,42,46 and a study from Singapore found rheumatic
heart disease in only 4% of endocarditis cases.48
Stroke
A population-based stroke registry in Iran found an incidence
of ischemic stroke of 43 per 100 000 population, with 11.8%
due to cardioembolism, in 45% of whom rheumatic heart
disease was detected.49 The authors concluded that rheumatic
heart disease caused 4.3 preventable strokes per 100 000
people per year in Iran.
Pregnancy and Rheumatic Heart Disease
An 18-year study in Taiwan found that stroke occurred in
46.2 of 100 000 pregnancies, and 44% of cases had underly-
ing rheumatic heart disease.50 Rheumatic heart disease was
the most common underlying condition (27% of cases) found
in pregnant patients admitted to the intensive care unit in a
Saudi Arabian hospital between 1997 and 2002.51 In an
Indian hospital between 1994 and 2000, rheumatic heart
disease accounted for 88% of cardiac diseases in pregnant
women.52
Discussion
It is often claimed that the burden of some infectious diseases
in Asia may be different from that in other parts of the world.
For example, there has been considerable discussion as to
whether there is evidence that Haemophilus influenzae type b
infections are less common in Asian children than in children
in other less-developed regions.53,54 Similarly, with the ex-
ception of a few countries in South-Central Asia (India,
Bangladesh, and Pakistan most prominently), there has been
little concern about rheumatic heart disease in most Asian
countries.
The data presented here suggest that rheumatic heart
disease is indeed an ongoing problem in Asia. Although the
regional estimates for prevalence in school-aged children
may not be as high as, for example, in sub-Saharan Africa, the
total burden of cases (between 10.8 and 15.9 million cases in
all ages) and deaths (356 000 to 524 000 each year) warrants
attention. Moreover, the 2 most rigorously performed studies,
from Pakistan and Cambodia, confirm that careful research
methodology will uncover many more cases than would
otherwise have been detected, which suggests that the true
number of rheumatic heart disease cases may be even greater
than presented here.4,9
The estimates presented here are only for clinically signif-
icant rheumatic heart disease, ie, for cases that as a minimum
have a murmur of rheumatic valvular disease. The Cambo-
dian study suggested that universal echocardiographic screen-
ing will uncover 10 subclinical rheumatic heart disease cases
for every clinical case.9 If this can be confirmed in other
studies, and if the significance of these subclinical cases is
found to be similar to clinical cases, then there is an immense
unrecognized burden of rheumatic heart disease in Asia that
requires urgent attention.
The Pakistan and Cambodia studies also highlight the
importance of high-quality epidemiological studies in devel-
oping countries. Such studies, using echocardiography to
confirm the diagnosis of rheumatic heart disease, are possi-
ble. Moreover, they are invaluable for providing the robust
estimates of disease burden on which public health strategies
must be based. It is clear from the studies outlined in Table 1
that there is a need for more and better studies from China and
the Asia Other countries, and accordingly, the summary
estimates from these places should be interpreted with
caution.
The studies on infective endocarditis confirm that in most
Asian countries, at least half of all cases of this severe and
often fatal disease are due to underlying rheumatic heart
disease, although in some countries with emerging middle
classes, this proportion is probably lower. Similarly, the
prospective stroke registry data from Iran support those in the
previous report that indicate that a substantial proportion of
strokes in developing countries are due to rheumatic heart
disease.49 If the incidence of strokes due to rheumatic heart
disease in Iran (4.3 per 100 000 people per year) were to be
applied to the population of Asia (3.9 billion), it could be
estimated that rheumatic heart disease causes 167 000 pre-
ventable strokes each year in Asia.
The compelling point about the data presented here is that
almost all of these cases, severe complications and deaths, are
preventable. Rheumatic heart disease can be prevented and
controlled with the establishment of register-based coordi-
nated control programs, the major focus of which is delivery
of secondary prophylaxis to prevent recurrences of rheumatic
fever.55 There is ample evidence that this strategy is cheap,
cost-effective, and practical in developing countries.56 With
the exception of some parts of a few countries in South-
Central Asia, I am not aware of coordinated control programs
in any Asian countries. Surely, it is time for health authorities
in Asian countries and international organizations such as the
World Health Organization to act on rheumatic heart disease
in this region.
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CLINICAL PERSPECTIVE
With the exception of India, there have been few population-based studies of the burden of rheumatic heart disease in Asian
countries; however, recent studies suggest that as with other developing regions of the world, rheumatic heart disease is
an underappreciated cause of morbidity and mortality in children, adolescents, and adults in low- and middle-income
countries of Asia. More importantly, it is likely that many cases of mild rheumatic heart disease remain undetected in Asian
children, with the risk that these lesions will progress to clinical significance as these children enter adulthood. Aside from
highlighting the need for better-quality data from Asia, the implications of these findings are that clinicians should have
a high index of suspicion of rheumatic heart disease when seeing children in this region, even if they are asymptomatic.
Moreover, the need for institution of formal rheumatic heart disease control programs and even for echocardiography-based
screening of school-aged children should be considered.
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